Emiri T Mandeville, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 12 | 2024 | 3007 | 1.370 |
Why?
|
Stroke | 17 | 2024 | 9755 | 1.060 |
Why?
|
Brain Edema | 3 | 2022 | 601 | 0.640 |
Why?
|
Infarction, Middle Cerebral Artery | 7 | 2024 | 485 | 0.540 |
Why?
|
Neural Stem Cells | 6 | 2022 | 895 | 0.510 |
Why?
|
Oligodendroglia | 4 | 2024 | 540 | 0.470 |
Why?
|
Blood-Brain Barrier | 4 | 2023 | 1035 | 0.440 |
Why?
|
Brain | 18 | 2023 | 27362 | 0.390 |
Why?
|
Neurogenesis | 5 | 2018 | 864 | 0.340 |
Why?
|
Cerebrovascular Circulation | 5 | 2024 | 2725 | 0.330 |
Why?
|
A Kinase Anchor Proteins | 2 | 2020 | 57 | 0.320 |
Why?
|
Neuroprotective Agents | 4 | 2024 | 958 | 0.290 |
Why?
|
Brain Infarction | 2 | 2019 | 286 | 0.260 |
Why?
|
Mice, Inbred C57BL | 14 | 2024 | 22380 | 0.240 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2018 | 2815 | 0.230 |
Why?
|
Ischemic Attack, Transient | 2 | 2022 | 877 | 0.230 |
Why?
|
Hypercapnia | 2 | 2023 | 259 | 0.230 |
Why?
|
Cerebral Hemorrhage | 4 | 2019 | 2654 | 0.210 |
Why?
|
Rats | 20 | 2023 | 23782 | 0.210 |
Why?
|
Corpus Callosum | 2 | 2024 | 752 | 0.210 |
Why?
|
Animals | 44 | 2024 | 169285 | 0.200 |
Why?
|
Microelectrodes | 1 | 2023 | 305 | 0.200 |
Why?
|
Unfolded Protein Response | 1 | 2024 | 239 | 0.200 |
Why?
|
Circadian Rhythm | 2 | 2024 | 2593 | 0.180 |
Why?
|
Recovery of Function | 4 | 2020 | 2981 | 0.180 |
Why?
|
Sphingosine | 1 | 2022 | 308 | 0.180 |
Why?
|
Astrocytes | 3 | 2022 | 1350 | 0.170 |
Why?
|
Endothelium, Lymphatic | 1 | 2019 | 63 | 0.170 |
Why?
|
Oxygen | 5 | 2024 | 4270 | 0.170 |
Why?
|
Antipyrine | 2 | 2016 | 40 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2019 | 125 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2019 | 118 | 0.160 |
Why?
|
Biological Transport | 1 | 2023 | 2085 | 0.160 |
Why?
|
Rats, Wistar | 7 | 2018 | 1890 | 0.160 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2013 | 418 | 0.160 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18349 | 0.160 |
Why?
|
Electrodes, Implanted | 1 | 2023 | 836 | 0.160 |
Why?
|
Microglia | 2 | 2020 | 1376 | 0.150 |
Why?
|
Blood Volume Determination | 1 | 2018 | 41 | 0.150 |
Why?
|
Free Radical Scavengers | 2 | 2016 | 213 | 0.150 |
Why?
|
Mitochondria | 2 | 2024 | 3683 | 0.150 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3445 | 0.150 |
Why?
|
Tissue Plasminogen Activator | 2 | 2013 | 1165 | 0.140 |
Why?
|
Endothelial Cells | 4 | 2023 | 3589 | 0.140 |
Why?
|
Mice | 20 | 2024 | 82049 | 0.140 |
Why?
|
Cerebral Cortex | 6 | 2023 | 5812 | 0.140 |
Why?
|
Ferrosoferric Oxide | 1 | 2018 | 348 | 0.140 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3858 | 0.130 |
Why?
|
Epidermal Growth Factor | 1 | 2019 | 697 | 0.130 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2018 | 3390 | 0.130 |
Why?
|
Serum Amyloid P-Component | 1 | 2016 | 46 | 0.130 |
Why?
|
Endothelium | 1 | 2018 | 768 | 0.130 |
Why?
|
Cell Lineage | 1 | 2024 | 2575 | 0.120 |
Why?
|
Spin Labels | 2 | 2018 | 336 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2016 | 2486 | 0.110 |
Why?
|
Annexin A2 | 1 | 2013 | 43 | 0.110 |
Why?
|
Pericytes | 1 | 2016 | 299 | 0.110 |
Why?
|
Amides | 1 | 2016 | 452 | 0.110 |
Why?
|
Isoquinolines | 1 | 2015 | 354 | 0.110 |
Why?
|
Lipocalins | 1 | 2014 | 161 | 0.110 |
Why?
|
Hemodynamics | 1 | 2024 | 4194 | 0.110 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 264 | 0.110 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 252 | 0.110 |
Why?
|
Neurons | 4 | 2024 | 9514 | 0.110 |
Why?
|
Carbon Monoxide | 1 | 2016 | 560 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 2016 | 648 | 0.100 |
Why?
|
Brain Chemistry | 1 | 2016 | 958 | 0.100 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2012 | 93 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 7 | 2019 | 8142 | 0.100 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2012 | 84 | 0.100 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2012 | 82 | 0.100 |
Why?
|
Glucose | 1 | 2024 | 4352 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1892 | 0.100 |
Why?
|
Intracranial Embolism | 1 | 2013 | 188 | 0.100 |
Why?
|
Echo-Planar Imaging | 2 | 2018 | 648 | 0.100 |
Why?
|
Myofibrils | 1 | 2012 | 143 | 0.100 |
Why?
|
Oxygen Consumption | 2 | 2015 | 1880 | 0.090 |
Why?
|
Microscopy | 2 | 2014 | 909 | 0.090 |
Why?
|
Antifibrinolytic Agents | 1 | 2013 | 289 | 0.090 |
Why?
|
Hemorrhage | 1 | 2022 | 3466 | 0.090 |
Why?
|
Nerve Tissue Proteins | 2 | 2020 | 4413 | 0.090 |
Why?
|
Isoflurane | 1 | 2013 | 384 | 0.090 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2013 | 706 | 0.090 |
Why?
|
Pattern Recognition, Automated | 1 | 2016 | 993 | 0.090 |
Why?
|
Cells, Cultured | 6 | 2024 | 19025 | 0.090 |
Why?
|
Dendrites | 1 | 2012 | 472 | 0.090 |
Why?
|
Radio Waves | 1 | 2011 | 250 | 0.080 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 3056 | 0.080 |
Why?
|
Protons | 2 | 2016 | 1113 | 0.080 |
Why?
|
Tomography, Optical Coherence | 2 | 2013 | 2957 | 0.080 |
Why?
|
Luminescent Measurements | 1 | 2011 | 342 | 0.080 |
Why?
|
Models, Cardiovascular | 1 | 2015 | 981 | 0.080 |
Why?
|
Pyrazines | 1 | 2015 | 1205 | 0.080 |
Why?
|
Cerebral Infarction | 3 | 2022 | 969 | 0.080 |
Why?
|
Male | 28 | 2024 | 364731 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8543 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1429 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2019 | 3474 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2237 | 0.070 |
Why?
|
Aging | 4 | 2024 | 8743 | 0.070 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2013 | 952 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2013 | 1320 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 2631 | 0.060 |
Why?
|
Rats, Inbred SHR | 2 | 2016 | 186 | 0.060 |
Why?
|
Brain Mapping | 2 | 2023 | 6684 | 0.060 |
Why?
|
Image Enhancement | 2 | 2016 | 2880 | 0.060 |
Why?
|
Culture Media, Conditioned | 2 | 2018 | 521 | 0.060 |
Why?
|
Cell Differentiation | 3 | 2018 | 11677 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2013 | 1162 | 0.060 |
Why?
|
Acute Disease | 4 | 2018 | 7243 | 0.060 |
Why?
|
Macrophages | 1 | 2019 | 5802 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2014 | 2420 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2012 | 1682 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36741 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3140 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8759 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4528 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2016 | 634 | 0.050 |
Why?
|
Cell Transdifferentiation | 1 | 2022 | 186 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7452 | 0.050 |
Why?
|
Capillaries | 2 | 2014 | 755 | 0.050 |
Why?
|
Nanoparticles | 1 | 2012 | 1986 | 0.050 |
Why?
|
Partial Pressure | 2 | 2011 | 248 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6669 | 0.040 |
Why?
|
Myocardium | 1 | 2012 | 4790 | 0.040 |
Why?
|
rho-Associated Kinases | 1 | 2020 | 290 | 0.040 |
Why?
|
Cell Membrane Permeability | 1 | 2020 | 573 | 0.040 |
Why?
|
Humans | 11 | 2024 | 768171 | 0.040 |
Why?
|
Microcirculation | 1 | 2023 | 1281 | 0.040 |
Why?
|
Lymphangiogenesis | 1 | 2019 | 171 | 0.040 |
Why?
|
Algorithms | 3 | 2016 | 14164 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2019 | 10478 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9540 | 0.040 |
Why?
|
Gelatin | 1 | 2019 | 231 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2016 | 2152 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2024 | 9561 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1003 | 0.030 |
Why?
|
Spleen | 1 | 2022 | 2296 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2020 | 4428 | 0.030 |
Why?
|
Models, Animal | 2 | 2014 | 2122 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2016 | 310 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13668 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2016 | 175 | 0.030 |
Why?
|
Neck | 1 | 2019 | 736 | 0.030 |
Why?
|
Maze Learning | 1 | 2016 | 482 | 0.030 |
Why?
|
Half-Life | 1 | 2015 | 651 | 0.030 |
Why?
|
Arterioles | 1 | 2014 | 251 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14488 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2018 | 652 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3517 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1900 | 0.030 |
Why?
|
Synaptophysin | 1 | 2013 | 138 | 0.030 |
Why?
|
Hydrogels | 1 | 2019 | 744 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 2016 | 911 | 0.030 |
Why?
|
Anions | 1 | 2012 | 137 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2013 | 752 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10763 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2013 | 271 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3428 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11095 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2013 | 462 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14729 | 0.020 |
Why?
|
Solubility | 1 | 2012 | 1086 | 0.020 |
Why?
|
Models, Chemical | 1 | 2012 | 611 | 0.020 |
Why?
|
Porphyrins | 1 | 2012 | 352 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1680 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 1028 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1587 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2357 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2015 | 1339 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1500 | 0.020 |
Why?
|
Blood Volume | 1 | 2011 | 545 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16726 | 0.020 |
Why?
|
Endovascular Procedures | 1 | 2023 | 2217 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2013 | 65379 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12252 | 0.020 |
Why?
|
Probability | 1 | 2014 | 2479 | 0.020 |
Why?
|
Materials Testing | 1 | 2012 | 873 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5028 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2016 | 1862 | 0.020 |
Why?
|
Anesthetics, Inhalation | 1 | 2013 | 573 | 0.020 |
Why?
|
Inflammation | 2 | 2019 | 10873 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20225 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2013 | 1264 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18415 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4149 | 0.020 |
Why?
|
Drug Discovery | 1 | 2015 | 1068 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4034 | 0.020 |
Why?
|
Nanotechnology | 1 | 2012 | 714 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1931 | 0.020 |
Why?
|
Biosensing Techniques | 1 | 2012 | 662 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1370 | 0.020 |
Why?
|
Ligands | 1 | 2012 | 3284 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7073 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2014 | 1448 | 0.020 |
Why?
|
Polymers | 1 | 2012 | 1630 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8052 | 0.020 |
Why?
|
Water | 1 | 2011 | 1421 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2013 | 2149 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1703 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1401 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6316 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2634 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1662 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3573 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8316 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5107 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5804 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8542 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4354 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5402 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9497 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5330 | 0.010 |
Why?
|
Aged | 3 | 2020 | 171502 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9617 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 6004 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6283 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59626 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23648 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22290 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 9016 | 0.010 |
Why?
|
Female | 3 | 2020 | 397187 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40220 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 30237 | 0.000 |
Why?
|
Middle Aged | 1 | 2012 | 223487 | 0.000 |
Why?
|